ZEPAT
Active compound · Yellow line
ZEPAT is a dual GIP and GLP-1 receptor agonist. Its mechanism is related to the modulation of glucose-dependent insulin secretion, reduced glucagon and the regulation of caloric intake. Lyophilized peptide in vial presentation, available in 5 mg, 10 mg and 20 mg — select the formulation that fits your protocol below.
Compound class Dual receptor agonist Molecular target GIP · GLP-1 Presentation Lyophilized vial + 2 ml Bac. water User satisfaction 98 %
Showing all 3 results
